PARTNER CONTENT

Drug Discovery Chemistry 2019 According to Pharm Exec and Evaluate Ltd., the top 10 biopharma companies in 2018 (Pfizer, Novartis, Roche, Merck & Co., Johnson & Johnson, Sanofi, GlaxoSmithKline, AbbVie, Gilead Sciences, and Amgen) generated $336 billion in prescription drug sales in 2017 along with a $63 billion investment in R&D. Always known for strong representation from industry,  Drug Discovery Chemistry  already includes participation from  9 of these top 10 biopharma companies  plus hundreds more. With the event still one month away, this representation will continue to grow. Don’t miss the   55+ presentations from top pharma   plus plenary keynotes from UCSF’s Dr. Jack Taunton and Dr. Frank McCormick. Learn More   |   View Brochure   |   REGISTER

Event-At-A-Glance

April 9-10 Protein-Protein Interactions Small Molecules for Cancer Immunotherapy Kinase Inhibitor Chemistry Fragment-Based Drug Discovery Directed Evolution-Based Drug Discovery

April 10-11 Ubiquitin-Proteasome System Inflammation Inhibitors Macrocyclics & Constrained Peptides GPCRs & Membrane Proteins Training Seminar: Drug Metabolism

April 12 AI for Early Drug Discovery Lead Optimization Blood-Brain Barrier Biophysical Approaches

SHORT COURSES (April 8 & 10)

DrugDiscoveryChemistry.com